This activity summarizes updates in screening, diagnostic, and treatment guidelines for hypertension, diabetes, and hyperlipidemia. Guidelines issued from the U.S. Preventative Services Taskforce (USPSTF), American College of Cardiology (ACC), American Heart Association (AHA), American Diabetes Association (ADA), American Association of Clinical Endocrinology (AACE), and other relevant entities will be discussed.

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Summarize current guidelines for hypertension, diabetes, and hyperlipidemia
• Recognize current screening guidelines from the USPSTF and other entities for identifying patients with hypertension, diabetes, and hyperlipidemia
• Apply current ACC/AHA diagnostic guidelines for hypertension and hyperlipidemia, and current ADA/AACE diagnostic guidelines for diabetes
• Choose optimal hypertension and hyperlipidemia management guidance from ACC/AHA, and interpret recent management updates as recommended in the 2023 ADA Standards of Care in Diabetes Guidelines
• Compare key differences in recommendations between various organizations